Navigation Links
Environmental Tectonics Corporation's BioMedical Division Announces New Contract
Date:10/4/2007

SOUTHAMPTON, Pa., Oct. 4 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (Amex: ETC) ("ETC" or the "Company") BioMedical Division announced today a contract award from a medical facility in Louisiana to supply two BARA-MED XD Monoplace Hyperbaric Chambers.

The BARA-MED XD is the industry's most technologically advanced chamber, featuring Windows(R)-based computer control software and automatic record keeping with printout capabilities. The BARA-MED XD also offers the SMOOTH*RIDE(TM) compression/decompression protocol, which is of special importance for patient comfort and safety as well as facility efficiency. ETC's BioMedical Systems Division strives to keep its equipment and customers at the forefront of hyperbaric medicine. In addition to their regular use in clinical treatments at medical facilities around the globe, the BARA-MED XD hyperbaric are routinely involved in the field of research, giving way to possible new HBO frontiers.

Gene Davis, President of ETC's BioMedical Division, commented, " I believe this contract is an affirmation of the company's design and production capability while demonstrating the competitiveness and overall market appeal of the company's BARA-MED XD chambers. ETC plans to continue to supply its customers with both well-designed and technologically advanced products in a competitive market."

ETC designs, develops, installs and maintains aircrew training systems (aeromedical, tactical combat and general), disaster management training systems and services, entertainment products, sterilizers (steam and gas), environmental testing products, hyperbaric chambers and related products for domestic and international customers.

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934. We have based these forward- looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about the Company that may cause our actual results, levels of activity, performance or achievements to be materially different from any other future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements include statements with respect to ETC's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of ETC, including but not limited to, (i) projections of revenue, costs of raw materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (ii) statements of plans and objectives of ETC or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (iii) statements of future economic performance, (iv) statements of assumptions and other statements about ETC or its business, (v) statements made about the possible outcomes of litigation involving ETC, and (vi) statements preceded by, followed by or that include the words "may", "could", "should", "looking forward", "would", "believe", "expect", "anticipate", "estimate", "intend", "plan", or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond ETC's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in our Securities and Exchange Commission filings and other public documents, including, without limitation, our Annual Report on Form 10-K for the fiscal rear ended February 23, 2007. Shareholders are urged to review these risks carefully prior to making an investment in the ETC's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. ETC does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of ETC.

Contact:

Duane D. Deaner, CFO

Environmental Tectonics Corporation

Tel: 215-355-9100 (ext. 1203)

Fax: 215-357-4000

ETC - Internet Home Page: http://www.etcusa.com


'/>"/>
SOURCE Environmental Tectonics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Analysis of Bacterial Assemblage Genetic Diversity in Environmental Samples Using the DCode System
2. Computer recycling: An environmental mandate the private sector can support
3. Environmental group works to run cars on Culvers old frying oil
4. Wisconsins Businesses Can Become Environmental Leaders
5. Corporations and blogging
6. Biomedical engineering conference invites manufacturers
7. Manufacturing partnership will move into biotech and biomedical spaces
8. Biomedical Alliance about more than stem cells
9. Doyle seeks $2.5M for biomedical alliance
10. Students will show off biomedical devices to professors and investors
11. Biomedical alliance marks first full year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... MD (PRWEB) , ... April 27, 2017 , ... ... (CAI) and a winner of the 43North Startup Competition, has truly taken their ... Cygnus spacecraft delivered Oncolinx’s innovative cancer experiments from Cape Canaveral to the International ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... internist, who will review how testing for 1,25-Dihydroxyvitamin D can enhance clinical practice. ... 25-OH-vitamin D and 1,25 dihydroxyvitamin D. , Dr. Gregory Plotnikoff, senior consultant with ...
(Date:4/27/2017)... Tenn. , April 27, 2017  Pendant Biosciences, ... developing innovative surface modification and drug delivery technologies, today ... Johnson Innovation, JLABS @ Toronto . ... Executive Officer of Pendant Biosciences, noted, "We are excited ... Toronto community, and are honored to be ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in ... to its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays ... able to offer NAT screening for blood donors under an Investigational New Drug (IND) ...
Breaking Biology Technology:
(Date:3/24/2017)... , March 24, 2017 The Controller General of ... Mr. Abdulla Algeen have received the prestigious international IAIR Award ... Continue Reading ... ... and Deputy Controller Abdulla Algeen (small picture on the right) have received ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
(Date:3/13/2017)... , March 13, 2017 Future of security: Biometric ... ... DERMALOGs Face Matching enables to match face pictures ... the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face ...
Breaking Biology News(10 mins):